CWGCX
Price
$68.12
Change
+$0.24 (+0.35%)
Updated
Jun 6 closing price
Net Assets
130.86B
LGCSX
Price
$18.46
Change
+$0.05 (+0.27%)
Updated
Jun 5 closing price
Net Assets
174.84M
Interact to see
Advertisement

CWGCX vs LGCSX

Header iconCWGCX vs LGCSX Comparison
Open Charts CWGCX vs LGCSXBanner chart's image
American Funds Capital World Gr&Inc C
Price$68.12
Change+$0.24 (+0.35%)
VolumeN/A
Net Assets130.86B
Lord Abbett Global Equity R4
Price$18.46
Change+$0.05 (+0.27%)
VolumeN/A
Net Assets174.84M
CWGCX vs LGCSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CWGCX vs. LGCSX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWGCX is a Buy and LGCSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWGCX has more cash in the bank: 131B vs. LGCSX (175M). CWGCX pays higher dividends than LGCSX: CWGCX (0.87) vs LGCSX (0.37). CWGCX was incepted earlier than LGCSX: CWGCX (24 years) vs LGCSX (8 years). LGCSX (1.72) is less costly to investors than CWGCX (1.49). LGCSX is a more actively managed with annual turnover of: 41.00 vs. CWGCX (27.00). LGCSX has a lower initial minimum investment than CWGCX: LGCSX (0) vs CWGCX (250). LGCSX annual gain was more profitable for investors over the last year : 14.44 vs. CWGCX (5.53). LGCSX return over 5 years is better than : 59.35 vs. CWGCX (42.30).
CWGCXLGCSXCWGCX / LGCSX
Total Expense Ratio1.490.90166%
Annual Report Gross Expense Ratio1.491.7287%
Fund Existence24 years8 years-
Gain YTD8.7119.77989%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets131B175M74,857%
Annual Yield % from dividends0.870.37235%
Returns for 1 year5.5314.4438%
Returns for 3 years26.8649.5354%
Returns for 5 years42.3059.3571%
Returns for 10 years49.31N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV6.200.47
+8.12%
Verve Therapeutics
PIII6.620.14
+2.24%
P3 Health Partners Inc
VSAT9.210.09
+0.99%
ViaSat
NLY19.060.18
+0.95%
Annaly Capital Management
RELI1.47-0.04
-2.65%
Reliance Global Group Inc.